Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$102.63
-2.34-2.23%
At close: Dec 15, 4:00 PM EST
$102.63
N/A
Pre-Market: 3:00 AM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Nuvalent (NUVL) stock?
You can purchase shares of Nuvalent (NASDAQ:NUVL) through any online brokerage.
Who are Nuvalent (NUVL) competitors?
Other companies in Nuvalent’s space includes: Avidity Biosciences Inc (NASDAQ:RNA), Cogent Biosciences Inc (NASDAQ:COGT), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and PTC Therapeutics Inc (NASDAQ:PTCT).
What is the forecast, or price target, for Nuvalent (NUVL) stock?
Nuvalent has a consensus price target of $122.57.
What is the current price for Nuvalent (NUVL)?
The stock price for Nuvalent (NASDAQ: NUVL) is $102.63 last updated December 16, 2025 at 4:02 PM EST.
Does Nuvalent (NUVL) pay a dividend?
There are no upcoming dividends for Nuvalent.
When is Nuvalent (NASDAQ:NUVL) reporting earnings?
Nuvalent does not have any upcoming earnings scheduled.
Is Nuvalent (NUVL) going to split?
There is no upcoming split for Nuvalent.
What sector and industry does Nuvalent (NUVL) operate in?
Nuvalent is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
